Moosaie, F., Abedinzadeh, S., Rabizadeh, S., Daneshvar, K., Noorafrooz, M., Mojtahedi, F. A., Deravi, N., Abhari, S. M. F., Ramezani, A., Meysamie, A., Hajibabaei, M., Reyhan, S. K., Abbaszadeh, M., Nakhjavani, M., Esteghamati, A. (2025). Empagliflozin-based quadruple oral therapy for type 2 diabetes: a prospective cohort study. Scientific Reports. https://doi.org/10.1038/s41598-024-84993-x